From January 1, 2024 to January 28, 2024, the company has repurchased 294,200 shares, representing 0.04% for CNY 1.65 million. With this, the company has completed the repurchase of 8,785,900 shares, representing 1.17% for CNY 50 million under the buyback announced on January 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.91 CNY | +0.41% | -0.61% | -11.21% |
1st Jan change | Capi. | |
---|---|---|
-11.21% | 477M | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+18.22% | 15.33B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.66B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.